DDAVP in Treatment of Vasopressin-Sensitive Diabetes Insipidus
- 13 July 1974
- Vol. 3 (5923) , 86-89
- https://doi.org/10.1136/bmj.3.5923.86
Abstract
In 11 patients with vasopressin-sensitive diabetes insipidus the effectiveness of the vasopressin analogue 1-desamino-8-D-arginine vasopressin (DDAVP) for controlling diabetes insipidus has been compared with that of lysine vasopressin. DDAVP in equivalent intravenous dosage has been found to be at least as potent and to have a more prolonged action, lasting 13-22 hours instead of 1-2 hours. Twice-daily intranasal DDAVP effected satisfactory control in all these patients, without side effects, and all the patients preferred this to their previous treatment. Single daily intramuscular injections of DDAVP were found to offer excellent control for any subject unable to manage intranasal administration.Keywords
This publication has 10 references indexed in Scilit:
- Vasopressin Analogue DDAVP in Diabetes Insipidus: Clinical and Laboratory StudiesBMJ, 1973
- EFFECTS OF DDAVP, A SYNTHETIC ANALOGUE OF VASOPRESSIN, IN PATIENTS WITH CRANIAL DIABETES INSIPIDUSActa Medica Scandinavica, 1972
- THE CLINICAL USE OF CHLORPROPAMIDE IN DIABETES INSIPIDUSActa Endocrinologica, 1971
- EFFECT OF A SYNTHETIC ANALOGUE OF VASOPRESSIN IN ANIMALS AND IN PATIENTS WITH DIABETES INSIPIDUSThe Lancet, 1968
- Hypersensitivity to pituitary snuff with miliary shadowing in the lungs.Thorax, 1967
- Antidiuretic Action of Chlorpropamide in Idiopathic Diabetes InsipidusJournal of Clinical Endocrinology & Metabolism, 1966
- [Does Tegretal offer new possibilities of therapy in several neurologic and endocrine diseases? A clinical electroencephalographic and thin-layer chromatographic study].1966
- Synthetic Vasopressin Nasal Spray in the Treatment of Diabetes InsipidusJAMA, 1964
- The effects of chlorothiazides in nephrogenic diabetes insipidus.1963
- Pituitary ablation by yttrium-90 implants for diabetic retinopathy.1962